Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, FibroGen (FGEN) has a market cap of $50.788 million USD. According to our data, FibroGen is ranked No.8145 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $50.79 M |
-4.91%
|
| Dec 31, 2024 | $53.41 M |
-40.18%
|
| Dec 29, 2023 | $89.28 M |
-94.47%
|
| Dec 30, 2022 | $1.61 B |
13.62%
|
| Dec 31, 2021 | $1.42 B |
-61.98%
|
| Dec 31, 2020 | $3.74 B |
-13.52%
|
| Dec 31, 2019 | $4.32 B |
-7.32%
|
| Dec 31, 2018 | $4.66 B |
-2.36%
|
| Dec 29, 2017 | $4.78 B |
121.50%
|
| Dec 30, 2016 | $2.16 B |
-29.77%
|
| Dec 31, 2015 | $3.07 B |
11.45%
|
| Dec 31, 2014 | $2.76 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
 Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
 Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
 Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
 Ultragenyx
RARE
|
$3.97 B |
0.000 M
|
USA
|
 bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
| Market Cap | = | FGEN Stock Price | * | FGEN Shares Outstanding |
| = | $0.50 | * | 0.10 B | |
| = | $50.79 M |